BRIEF published on 07/30/2025 at 11:43, 1 year ago Medincell Releases 2024-25 Universal Registration Document Shareholders Governance Financial Report CSR Medincell
PRESS RELEASE published on 07/30/2025 at 11:38, 1 year ago Annual financial and audit reports / Terms of availability of the annual financial report Medincell announces availability of its 2024-25 Universal Registration Document, including financial and CSR reports. Innovative treatments developed aim to improve effectiveness of medicines Financial Reports Universal Registration Document CSR Innovative Treatments Medincell
BRIEF published on 05/07/2025 at 15:17, 1 year 3 months ago Medincell's Growth in Antipsychotic Treatments FDA Filing Medincell Olanzapine LAI UZEDY Antipsychotics
PRESS RELEASE published on 05/07/2025 at 15:12, 1 year 3 months ago Inside Information / Other news releases Medincell's UZEDY® sees strong sales growth in Q1 2025 with plans for Olanzapine LAI FDA submission in H2 2025. Teva's partner shares updates on key products Medincell FDA Submission Teva Pharmaceuticals Olanzapine LAI UZEDY
BRIEF published on 04/15/2025 at 19:53, 1 year 3 months ago Medincell increases its liquidity contract to support securities trading Liquidity Contract Rothschild Martin Maurel Actions EU Regulations Medincell
PRESS RELEASE published on 04/15/2025 at 19:48, 1 year 3 months ago Inside Information / Other news releases Medincell increases liquidity contract resources by 600,000 euros with Rothschild Martin Maurel to support higher trading volumes Liquidity Contract Rothschild Martin Maurel Amendment Medincell Trading Volumes
BRIEF published on 03/10/2025 at 11:54, 1 year 5 months ago Adage Capital exceeds 5% in MEDINCELL Euronext Paris Actions Threshold Crossing Medincell Adage Capital
BRIEF published on 02/25/2025 at 23:08, 1 year 5 months ago FDA Accepts Application for UZEDY's Use in Treating Bipolar I Disorder FDA Approval Medincell Teva Pharmaceuticals UZEDY Bipolar I Disorder
PRESS RELEASE published on 02/25/2025 at 23:03, 1 year 5 months ago Inside Information / Other news releases Teva and Medincell announce FDA acceptance of UZEDY(R) risperidone for bipolar I disorder treatment, expanding indications for this long-acting injectable antipsychotic FDA Medincell Teva UZEDY Bipolar I Disorder
BRIEF published on 02/19/2025 at 08:33, 1 year 5 months ago Medincell successfully completes its Global Offer of 42.9 million euros Fundraising International Investors Medincell Global Offer BEPO® Technology
Published on 08/12/2026 at 12:30, 18 minutes ago Relevant Gold Commences 5,000-Metre Drill Program and Updates Exploration Model at the Lewiston Project in Wyoming, USA
Published on 08/12/2026 at 11:30, 1 hour 18 minutes ago American Critical Minerals Announces the Execution of the Drilling Contract with Drake Well Service and Mobilization to the Green River Project
Published on 08/12/2026 at 09:01, 3 hours 47 minutes ago Apex Drills 4.48% REO Over 8.0 m and 5.27% REO Over 10.2 m Within Multiple ~ 150 m Intervals of > 2.00 % REO at the Rift Rare Earth Project in SE Nebraska
Published on 08/12/2026 at 08:02, 4 hours 46 minutes ago Southern Energy Corp. Announces Spudding of Cotton Valley Test Well at Williamsburg and Appointment of Market Maker
Published on 08/12/2026 at 08:00, 4 hours 48 minutes ago Galantas Selects Engineering and Mine Planning Contractors for Andacollo Gold Project
Published on 08/12/2026 at 12:21, 27 minutes ago EQS-Adhoc: Klöckner & Co SE: Delisting will take effect on August 12, 2026 in accordance with the resolution of the Frankfurt Stock Exchange
Published on 08/12/2026 at 11:50, 58 minutes ago German Offtake Partner to Double Volumes to 40,000 tpa
Published on 08/12/2026 at 11:47, 1 hour ago SME bond market H1 2026: Issuance activity picks up, placement becomes more challenging
Published on 08/12/2026 at 11:31, 1 hour 16 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 08/12/2026 at 11:29, 1 hour 18 minutes ago EQS-Adhoc: Valour Digital Securities Limited: Compulsory Redemption by the Issuer
Published on 08/10/2026 at 18:00, 1 day 18 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 11:53, 2 days ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 2 days 1 hour ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 2 days 3 hours ago Number of shares and voting rights - July 2026 (In French only)
